IMMUCELL CORP /DE/

ImmuCell Corporation is an animal health company that develops and manufactures products focused on improving cattle health and productivity. The company operates primarily in two therapeutic areas: calf scours prevention and dairy cow mastitis management. Its scours portfolio includes First Defense, an orally delivered preventive for calves targeting E. coli, coronavirus, and rotavirus, along with Tri-Shield First Defense, a passive antibody product for treatment of the same pathogens. For mastitis management, ImmuCell offers the California Mastitis Test, an on-farm diagnostic used to detect somatic cell counts and identify affected udder quarters, as well as Dual-Force First Defense, a bivalent gel formulation.

The company operates through its Scours and Mastitis segments, selling products to U.S. and international markets primarily through animal health distributors. ImmuCell also has a product in development, Re-Tain, a Nisin-based intramammary treatment candidate for subclinical mastitis in lactating dairy cows. The company is based in Portland, Maine and operates with approximately 77 full-time employees. ImmuCell was incorporated in Delaware in 1982.